跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
CIMA-AEMPS
/
LEVOSIMENDAN KALCEKS 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Approved
STANDARD
LEVOSIMENDAN KALCEKS 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Kalceks As
🇪🇸 Spanish Agency of Medicines and Medical Devices
Approval Date
Mar 28, 2022
Approval ID
ec9e1c5bb7c9403b
Company
Kalceks As
Type
Standard
Approval Details
Approval Id
ec9e1c5bb7c9403b
Drug Cima Aemps Name
LEVOSIMENDAN KALCEKS 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG
Register Number
86702
Holder Company Name
Kalceks As
Marketing Company Name
Grindeks Kalceks Espana S.L.
Authorization Date
2022-03-28
Dosage Form
CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose
2,5 mg/ml
Route Of Administration
VÍA INTRAVENOSA
Prescription Type
Uso Hospitalario
Commercialized
No
Company Name
Kalceks As
Active Ingredients
LEVOSIMENDAN
2,5 mg
Approved
Quick Info
Agency
CIMA-AEMPS
Country
🇪🇸
Approval Date
Mar 28, 2022
Approval ID
ec9e1c5bb7c9403b
Type
Standard
Back to CIMA-AEMPS Approvals
LEVOSIMENDAN KALCEKS 2,5 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION EFG - CIMA-AEMPS Drug Approval Details